ONCOSIL MEDICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 AUD | +25.00% |
|
+25.00% | -44.44% |
| 05-02 | OncoSil Medical Raises AU$5.3 Million under Entitlement Offer | MT |
| 04-18 | OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial | MT |
Chart calendar OncoSil Medical Limited
edfff2c9cd691369de49ddef44e9.-xwMqSPgjeb329E8RIIgSQh1xcDtv3AGSLdYgWF75Ys.tW1L7kiixNKdkrVNKOx2G240g-27_CNnIcQh1VUtn9KMf1v-E9n_ipO-lA~8c659a9dfff0b83d17ee2681650c76ff
Upcoming events on OncoSil Medical Limited
Past events on OncoSil Medical Limited
| 26/03/2024 | Rights Issue: 1 new share @ 0.005 AUD for 2 existing shares |
| 20/03/2024 | Stock Network ASX Gems Conference |
| 28/02/2024 06:22 | Q2 2024 Earnings Release |
| 31/01/2024 00:30 | December 2023 Sales and Revenue Release - Activities Report |
| 28/11/2023 23:30 | Annual General Meeting |
| 30/10/2023 03:49 | September 2023 Sales and Revenue Release - Activities Report |
| 31/08/2023 07:56 | Q4 2023 Earnings Release |
| 28/07/2023 00:50 | June 2023 Sales and Revenue Release |
| 28/06/2023 | European Society for Medical Oncology World Gastrointestinal Cancer Congress |
| 28/04/2023 07:06 | March 2023 Sales and Revenue Release - Activities Report |
| 20/04/2023 | The Mayo Clinic IMPACT Conference |
| 21/03/2023 | Rights Issue: 1 new share @ 0.01 AUD for 1 existing share |
| 28/02/2023 05:19 | Q2 2023 Earnings Release |
| 31/01/2023 00:37 | December 2022 Sales and Revenue Release - Activities Report |
| 07/11/2022 00:30 | TechKnow Invest Conference |
| 30/10/2022 | September 2022 Sales and Revenue Release - Activities Report |
| 26/10/2022 | AusBioInvest Conference |
| 25/10/2022 02:00 | Annual General Meeting |
| 19/10/2022 03:45 | Canaccord Genuity South-West ASX Showcase |
| 30/08/2022 | FY 2022 Earnings Release |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,00 0,00 - | 2,96 0,00 - | 0,21 0,19 12.74% | 0,23 0,11 106.96% |
|
EBITDA Million AUD | Released Forecast Spread | -8,53 -9,62 11.37% | -4,10 -6,93 40.84% | -10,2 -10,2 -0.77% | -10,5 -9,66 -8.84% |
|
EBIT Million AUD | Released Forecast Spread | -8,57 -9,63 11.06% | -4,25 -6,89 38.34% | -10,4 -10,2 -2.13% | -10,7 -9,77 -9.56% |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -8,57 -9,20 6.88% | -4,26 -7,70 44.65% | -10,4 -9,60 -8.68% | -10,7 0,00 - |
|
Net income Million AUD | Released Forecast Spread | -8,57 -9,26 7.53% | -4,26 -6,78 37.17% | -10,4 -10,1 -3.18% | -10,7 -9,71 -10.47% |
|
EPS AUD | Released Forecast Spread | -0,01 -0,01 13.88% | -0,01 -0,01 29.26% | -0,01 -0,01 6.64% | -0,01 -0,01 -13.36% |
| Announcement Date | 22/08/19 | 19/08/20 | 18/08/21 | 30/08/22 |
More events
Past sector events for OncoSil Medical Limited
| 03/05/2024 12:07 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 03/05/2024 11:00 | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 21:01 | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 18:43 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:30 | ORGANON & CO.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 02/05/2024 06:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 01/05/2024 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OSL Stock
- Calendar OncoSil Medical Limited
